Indian Pharmaceutical Alliance drops Sovaldi opposition

16-09-2015

Indian Pharmaceutical Alliance drops Sovaldi opposition

Aleksandar Mijatovic / Shutterstock.com

The Indian Pharmaceutical Alliance (IPA) has dropped its opposition to a patent application filed by Gilead Sciences covering its hepatitis C drug Sovaldi (sofosbuvir).


Gilead, Sovaldi, Indian Pharmaceutical Alliance, patent, Indian Patent Office

LSIPR